Roger Appelqvist

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

AI-based digital pathology and spatial proteomics enable precision oncology: A case report of recurrent melanoma in a young patient.

AI-based digital pathology and spatial proteomics enable precision oncology: A case report of recurrent melanoma in a young patient.

Journal: NPJ precision oncology
Published: October 20, 2025

Distant metastases of melanoma exhibit varying extent of intrapatient proteogenomic heterogeneity.

Distant metastases of melanoma exhibit varying extent of intrapatient proteogenomic heterogeneity.

Journal: Clinical and translational medicine
Published: May 16, 2025

Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT.

Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT.

Journal: Journal of proteome research
Published: May 05, 2025

The melanoma MEGA-study: Integrating proteogenomics, digital pathology, and AI-analytics for precision oncology.

The melanoma MEGA-study: Integrating proteogenomics, digital pathology, and AI-analytics for precision oncology.

Journal: Journal of proteomics
Published: February 03, 2025

Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.

Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.

Journal: Cancers
Published: January 24, 2025

Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center.

Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center.

Journal: Journal of proteomics
Published: January 17, 2025

Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies.

Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies.

Journal: Cancer
Published: December 17, 2024

Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes.

Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes.

Journal: International journal of dermatology
Published: October 02, 2024

Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.

Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.

Journal: bioRxiv : the preprint server for biology
Published: May 15, 2024

Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.

Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.

Journal: Frontiers in oncology
Published: May 05, 2024

Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target Prediction.

Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target Prediction.

Journal: bioRxiv : the preprint server for biology
Published: March 28, 2024

Mitochondrial and immune response dysregulation in melanoma recurrence.

Mitochondrial and immune response dysregulation in melanoma recurrence.

Journal: Clinical and translational medicine
Published: September 29, 2023
Showing 1-12 of 36

Last Updated: 09/26/2026